Volume 12, Number 7—July 2006
Dispatch
Azithromycin Failure in Mycoplasma genitalium Urethritis
Table
Patient† | TOC-1 |
TOC-2 |
TOC-3 |
TOC-4 |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Pretreatment PMN/HPF | PMN/HPF | Mg PCR | Treatment-2 | PMN/HPF | Mg PCR | Treatment-3 | PMN/HPF | Mg PCR | Treatment-4 | Mg PCR | |
1‡ | >5 | >5 | Pos | 1 g AZI | >5 | Pos | 1 g AZI weekly, 3 doses | <5 | Pos | MOX, 400 mg daily 10 d | Neg |
2‡ | >5 | <5 | Pos | 1 g AZI | § | Pos | 1 g AZI weekly, 3 doses | § | Pos | Moxifloxacin, 400 mg daily 10 d | Neg |
3 | <5 | § | Pos | 1 g AZI weekly 3 doses | <5 | Pos | MOX, 400 mg daily 10 d | § | Neg | ||
4‡¶ | >5 | >5 | Pos | MOX, 400 mg daily 10 d | Neg | ||||||
5‡ | >5 | >5 | Pos | MOX, 400 mg daily 10 d | Neg | ||||||
6 | <5 | § | Pos | MOX, 400 mg daily 10 d | Neg | ||||||
7# | >5 | <5 | Pos | MOX, 400 mg daily 10 d | Neg | ||||||
8 | >5 | <5 | Pos | MOX, 400 mg daily 10 d | Neg | ||||||
9 | >5 | >5 | Pos | MOX, 400 mg daily 10 d | Neg |
*PMN/HPF, polymorphonuclear count per high power field (×1,000 magnification); Mg, Mycoplasma genitalium; PCR, polymerase chain reaction; Pos, positive; Neg, negative; AZI, azithromycin; MOX, moxifloxacin; d, days; bd, twice daily; tests of cure (TOCs) were performed 1 month after commencement of each therapy; TOC-1, first test of cure 1 month after treatment.
†All men treated with 1 g of azithromycin at first examination.
‡Patients with specimens cultured, MIC data available and presented for all 4 isolates.
§Urethral PMN count not available.
¶Patient 4 saw his general practitioner 3 weeks after receiving 1 g azithromycin with recurrent urethral discharge and dysuria and was retreated with 1 g azithromycin before his TOC-1.
#Only patient who was asymptomatic with persistent infection.